Clinical Research Services

Clinical Research Services is an essential shared resource that provides centralized, integrated, and coordinated support for cancer clinical trials conducted through Yale Cancer Center.  Patients enrolled in cancer clinical trials are most frequently cared for at Smilow Cancer Hospital at Yale-New Haven and at the Smilow Cancer Hospital Care Centers throughout Connecticut.  Yale Cancer Center’s clinical trial portfolio includes over 100 active trials, providing options beyond the standard of care for patients with most types of cancers.  Each year, over 450 patients choose to participate in one of our clinical trials as part of their care plan developed by their physician.

Clinical Research Services is comprised of the Clinical Trials Office and Office of Protocol Review and Monitoring, as well as resources for contracts and budgeting and protocol development.  A Steering Committee, Protocol Review Committee, and Data Safety Monitoring Committee oversee all clinical trial activities for Yale Cancer Center, along with the Institutional Review Board (IRB) and Human Investigations Committee (HIC) at Yale School of Medicine.
In 2012, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven signed a collaboration with Sarah Cannon Research Institute (SCRI), a national leader in clinical trials, to accelerate the process of bringing the latest scientific advances to patients at Yale and across the country.  This unique collaboration will build on Sarah Cannon’s experience in managing cancer clinical trials and Yale Cancer Center’s innovative translational research efforts to create more opportunities for patients to participate in clinical trials.